Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6
- PMID: 23756852
- DOI: 10.1007/s00424-013-1306-0
Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6
Abstract
Proton pump inhibitors (PPIs) are potent blockers of gastric acid secretion, used by millions of patients suffering from gastric acid-related complaints. Although PPIs have an excellent safety profile, an increasing number of case reports describe patients with severe hypomagnesemia due to long-term PPI use. As there is no evidence of a renal Mg²⁺ leak, PPI-induced hypomagnesemia is hypothesized to result from intestinal malabsorption of Mg²⁺. The aim of this study was to investigate the effect of PPIs on Mg ²⁺homeostasis in an in vivo mouse model. To this end, C57BL/6J mice were treated with omeprazole, under normal and low dietary Mg²⁺ availability. Omeprazole did not induce changes in serum Mg²⁺ levels (1.48 ± 0.05 and 1.54 ± 0.05 mmol/L in omeprazole-treated and control mice, respectively), urinary Mg²⁺ excretion (35 ± 3 μmol/24 h and 30 ± 4 μmol/24 h in omeprazole-treated and control mice, respectively), or fecal Mg²⁺ excretion (84 ± 4 μmol/24 h and 76 ± 4 μmol/24 h in omeprazole-treated and control mice, respectively) under any of the tested experimental conditions. However, omeprazole treatment did increase the mRNA expression level of the transient receptor potential melastatin 6 (TRPM6), the predominant intestinal Mg²⁺ channel, in the colon (167 ± 15 and 100 ± 7 % in omeprazole-treated and control mice, respectively, P < 0.05). In addition, the expression of the colonic H⁺,K⁺-ATPase (cHK-α), a homolog of the gastric H⁺,K⁺-ATPase that is the primary target of omeprazole, was also significantly increased (354 ± 43 and 100 ± 24 % in omeprazole-treated and control mice, respectively, P < 0.05). The expression levels of other magnesiotropic genes remained unchanged. Based on these findings, we hypothesize that omeprazole inhibits cHK-α activity, resulting in reduced extrusion of protons into the large intestine. Since TRPM6-mediated Mg²⁺absorption is stimulated by extracellular protons, this would diminish the rate of intestinal Mg²⁺ absorption. The increase of TRPM6 expression in the colon may compensate for the reduced TRPM6 currents, thereby normalizing intestinal Mg²⁺ absorption during omeprazole treatment in C57BL/6J mice, explaining unchanged serum, urine, and fecal Mg²⁺ levels.
Similar articles
-
Characterization of intestine-specific TRPM6 knockout C57BL/6 J mice: effects of short-term omeprazole treatment.Pflugers Arch. 2025 Jan;477(1):99-109. doi: 10.1007/s00424-024-03017-9. Epub 2024 Sep 13. Pflugers Arch. 2025. PMID: 39266724 Free PMC article.
-
Effect of prolonged omeprazole administration on segmental intestinal Mg2+ absorption in male Sprague-Dawley rats.World J Gastroenterol. 2020 Mar 21;26(11):1142-1155. doi: 10.3748/wjg.v26.i11.1142. World J Gastroenterol. 2020. PMID: 32231419 Free PMC article.
-
Omeprazole suppressed plasma magnesium level and duodenal magnesium absorption in male Sprague-Dawley rats.Pflugers Arch. 2016 Nov;468(11-12):1809-1821. doi: 10.1007/s00424-016-1905-7. Epub 2016 Nov 19. Pflugers Arch. 2016. PMID: 27866273
-
Mechanisms of proton pump inhibitor-induced hypomagnesemia.Acta Physiol (Oxf). 2022 Aug;235(4):e13846. doi: 10.1111/apha.13846. Epub 2022 Jun 14. Acta Physiol (Oxf). 2022. PMID: 35652564 Free PMC article. Review.
-
Molecular determinants of magnesium homeostasis: insights from human disease.J Am Soc Nephrol. 2008 Aug;19(8):1451-8. doi: 10.1681/ASN.2008010098. Epub 2008 Jun 18. J Am Soc Nephrol. 2008. PMID: 18562569 Free PMC article. Review.
Cited by
-
Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger-Ellison Syndrome.Int J Mol Sci. 2019 Oct 16;20(20):5128. doi: 10.3390/ijms20205128. Int J Mol Sci. 2019. PMID: 31623145 Free PMC article. Review.
-
Association of Magnesium Depletion Score With Cardiovascular Disease and Its Association With Longitudinal Mortality in Patients With Cardiovascular Disease.J Am Heart Assoc. 2023 Sep 19;12(18):e030077. doi: 10.1161/JAHA.123.030077. Epub 2023 Sep 8. J Am Heart Assoc. 2023. PMID: 37681518 Free PMC article.
-
Routine hemodialysis induces a decline in plasma magnesium concentration in most patients: a prospective observational cohort study.Sci Rep. 2018 Jul 6;8(1):10256. doi: 10.1038/s41598-018-28629-x. Sci Rep. 2018. PMID: 29980722 Free PMC article.
-
Magnesium Administration in Chronic Kidney Disease.Nutrients. 2023 Jan 20;15(3):547. doi: 10.3390/nu15030547. Nutrients. 2023. PMID: 36771254 Free PMC article. Review.
-
Magnesium: A Magic Bullet for Cardiovascular Disease in Chronic Kidney Disease?Nutrients. 2019 Feb 22;11(2):455. doi: 10.3390/nu11020455. Nutrients. 2019. PMID: 30813254 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials